학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 197건 | 목록 1~20
Academic Journal
Kennecke H; Professor of Medicine, Division of Medical Oncology and Hematology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Delpassand E; Department of Nuclear Medicine, Excel Diagnostics & Nuclear Oncology Center, Houston, TX, USA.; Felder S; Department of Gastrointestinal Surgical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Gleeson F; Department of Gastroenterology, Mayo Clinic, Rochester, MN, USA.; Hallet J; Department of Surgery, Sunnybrook Research Institute, Toronto, ON, Canada.; Horowitz D; Department of Radiation Oncology, Columbia University Irving Medical Center, 622 West 168Street, New York, NY, USA.; Hyrcza M; Department of Pathology and Laboratory Medicine, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.; Katona BW; Department of Gastroenterology and Hepatology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.; Kiely M; Colon and Rectal Surgery, Johns Hopkins Medicine, Baltimore, MD, USA.; Kim M; Department of Gastroenterology, Cleveland Clinic, Cleveland, OH, USA.; Mallak N; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA.; Parkins V; Department of Endocrinology, University of Calgary, Calgary, AB, Canada.; Varma MG; Department of Surgery, University of California San Francisco, San Francisco, CA, USA.; Pasieka J; Department of Surgical Oncology, University of Calgary, Calgary, AB, Canada.
Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE
Academic Journal
Mahalingam D; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Owonikoko TK; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Delpassand E; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, USA.; Mulcahy MF; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Kalyan A; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Ulahannan S; Stephenson Cancer Center, University of Oklahoma Health Sciences Center/Sarah Cannon Research Institute, Oklahoma City, Oklahoma, USA.; Cheung K; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Izumi Y; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Johansen M; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Madden T; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Shimoyama S; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Subach RA; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Suzuki T; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Wages DS; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Wheeler C; FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.; Richardson DL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center/Sarah Cannon Research Institute, Oklahoma City, Oklahoma, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Askari E; Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Moghadam SZ; Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Wild D; ENETS Center of Excellence, Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland.; Delpassand E; Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, Houston, Texas.; Baldari S; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, University of Messina, Messina, Italy.; Nilica B; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.; Hartrampf PE; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.; Kong G; Sir Peter MacCallum Department of Oncology and Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Grana CM; Division of Nuclear Medicine, European Institute of Oncology, IRCCS, Milan, Italy.; Alexander Walter M; Nuclear Medicine and Molecular Division, Geneva Medical Hospital, Geneva, Switzerland.; Capoccetti F; UOC Nuclear Medicine-PET Center-Single Regional Center for Radiometabolic Therapy, Department of Radiological Diagnosis and Services, ASUR Marche Area Vasta 3, Macerata, Italy.; Kasi PM; Meyer Cancer Center and Englander Institute of Precision Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York; and.; Strosberg J; Neuroendocrine Tumor Division, Gastrointestinal Department, Moffitt Cancer Center, Tampa, Florida jonathan.strosberg@moffitt.org.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0430303 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5675 (Electronic) Linking ISSN: 00914916 NLM ISO Abbreviation: J Nucl Med Technol Subsets: MEDLINE
Academic Journal
Radiologic Clinics of North America. 31(4):923-933
Patent
Academic Journal
Strosberg J; Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, Tampa, FL, USA. jonathan.strosberg@moffitt.org.; Kunz PL; Department of Medicine - Med/Oncology, Stanford University Medical Center, Stanford, CA, USA.; Hendifar A; Department of Internal Medicine/Hematology/Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.; Yao J; Department of Gastrointestinal Medicinal Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bushnell D; Department of Radiology, The University of Iowa, Iowa City, IA, USA.; Kulke MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Baum RP; Department of Nuclear Medicine, Zentralklinik Bad Berka, Bad Berka, Germany.; Caplin M; Department of Gastroenterology and Tumour Neuroendocrinology, Royal Free Hospital, London, UK.; Ruszniewski P; Division of Gastroenterology and Pancreatology, Hôpital Beaujon, Clichy, France.; Delpassand E; Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, Houston, TX, USA.; Hobday T; Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.; Verslype C; Department of Hepatology, University Hospitals and KU Leuven, Leuven, Belgium.; Benson A; Hematology Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.; Srirajaskanthan R; Department of Gastroenterology and General Internal Medicine, King's College Hospital - NHS Foundation Trust, London, UK.; Pavel M; Division of Hepatology and Gastroenterology, Charite-Universitätsmedizin Berlin, Berlin, Germany.; Mora J; Department of Nuclear Medicine, Hospital Universitari de Bellvitge, Barcelona, Spain.; Berlin J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Grande E; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.; Reed N; Department of Medical Oncology, Beatson Oncology Centre, Glasgow, UK.; Seregni E; Department of Nuclear Medicine Therapy and Endocrinology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.; Paganelli G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.; Severi S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.; Morse M; Department of Surgery, Duke University Medical Center, Durham, NC, USA.; Metz DC; GI Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Ansquer C; Nuclear Medicine Department, Hôtel Dieu, University Hospital, Nantes, France.; Courbon F; Medical Imaging, Oncology University Institut Claudius Regaud, Toulouse, France.; Al-Nahhas A; Division of Imaging and Interventional Radiology, Imperial College London, London, UK.; Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France.; Giammarile F; Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.; Taïeb D; Department of Nuclear Medicine, Hôpital de la Timone, Marseille, France.; Mittra E; Department of Nuclear Medicine, Oregon Health & Science University, Portland, OR, USA.; Wolin E; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; O'Dorisio TM; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.; Lebtahi R; Department of Nuclear Medicine, Royal Free Hospital, London, UK.; Deroose CM; Nuclear Medicine Department, University Hospitals and KU Leuven, Leuven, Belgium.; Grana CM; Division of Nuclear Medicine, Istituto Europeo di Oncologia, Milan, Italy.; Bodei L; Department of Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Öberg K; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.; Polack BD; Department of Medical Information, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; He B; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Mariani MF; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Gericke G; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Santoro P; Department of Clinical Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Erion JL; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Ravasi L; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Krenning E; Department of Nuclear Medicine, Cyclotron Rotterdam BV, Erasmus University Medical Center, Rotterdam, Netherlands.
Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Academic Journal
Calais JCzernin JThin P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gartmann J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Allen-Auerbach MQuon ABahri SGupta P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gardner L; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Dahlbom M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; He B; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.; Esfandiari R; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; Ranganathan D; RadioMedix, Inc., Houston, Texas.; Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and.; Eiber M; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany.; Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and.; Delpassand E; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; RadioMedix, Inc., Houston, Texas.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med
Academic Journal
Calais JGafita A; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Eiber M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany.; Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gartmann J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Thin P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Lok V; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gosa L; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Grogan T; Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Esfandiari R; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; Allen-Auerbach M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Quon A; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Bahri S; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Gupta P; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Gardner L; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Ranganathan D; RadioMedix, Inc., Houston, Texas; and.; Slavik R; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Dahlbom M; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Physics & Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Herrmann K; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.; Delpassand E; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.; RadioMedix, Inc., Houston, Texas; and.; Fendler WP; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.; Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med
검색 결과 제한하기
제한된 항목
[검색어] Delpassand E
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어